Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health    CVS

CVS HEALTH (CVS)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Court Rules Two CVS Florida Pharmacies Can't Ship Pain Pills

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/22/2012 | 11:59pm CET
   By John Kell 
   Of  
 

A U.S. appeals court said two CVS Caremark Corp. (>> CVS Caremark Corporation) pharmacies in Florida cannot fill prescriptions for certain controlled drugs related to a Drug Enforcement Administration move to halt such sales.

The decision lifted a temporary, administrative stay that was granted to CVS earlier this month, at the time allowing the pharmacies to keep dispensing controlled medications after an appeals court denied the chain's request for preliminary injunction.

The case stems from DEA action that was taken last month against two Sanford, Fla., CVS stores that were alleged to be among four pharmacy customers of drug distributor Cardinal Health Inc. (CAH) that dispensed the pain drug oxycodone based on bad prescriptions.

The U.S. Court of Appeals for the District of Columbia Circuit on Thursday ruled CVS had "not satisfied the stringent requirements for a stay pending appeal." The decision comes roughly a week after an appeals court said a Cardinal Health distribution hub in Florida can't ship prescription painkillers.

In a prepared statement, CVS said it was "disappointed with today's ruling by the court," saying the company had taken actions that have substantially reduced the amount of oxycodone dispensed at the two Florida pharmacies.

"We remain committed to working with the DEA to do everything we can to reduce prescription drug abuse," CVS said.

-By John Kell, Dow Jones Newswires; 212-416-2480; [email protected]

-Jon Kamp and Timothy Martin of The Wall Street Journal contributed to this article

Stocks mentioned in the article : CVS Caremark Corporation
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CVS HEALTH
12/12 CVS HEALTH : 3 Reasons Why Florida Addiction Recovery Center CEO Is Wary Of $77 ..
12/11 CVS HEALTH : 3 Reasons Why Florida Addiction Recovery Center CEO Is Wary Of $77 ..
12/08 CVS expects U.S. Justice Department to handle review of Aetna deal
12/08 CVS HEALTH : A.M. Best Places Credit Ratings of SilverScript Insurance Company U..
12/08 CVS HEALTH : Greg's Pharmacy, Bluffton, will become a CVS Pharmacy
12/07 MYERS INDUSTRIES : Names Chris DuPaul as Group President, Distribution
12/07 CVS HEALTH : Meningitis B Vaccine Available to Students, Faculty and Staff at UM..
12/07 CVS HEALTH : Reminds Families It's Not Too Late to Get Their Flu Shot During Nat..
12/07 CVS HEALTH : UnitedHealth ventures deeper with nearly $5B deal
12/07 AETNA : CVS to keep Aetna name 5 years after acquisition CVS to keep Aetna name ..
More news
News from SeekingAlpha
08:26a The Value Of Reliability And Why Omega Healthcare Is A Value Trap
03:03a I'm Sticking With CVS And Walgreens, My Last Two Losers
12/11 CVS AND AETNA : The Worst Of Sick-Care Under One Roof
12/11 Sell CVS Before The Inevitable Credit Downgrade And Balance Sheet Destruction
12/11 CVS & AETNA : Are The Risks Worth The Rewards?
Financials ($)
Sales 2017 184 B
EBIT 2017 10 083 M
Net income 2017 5 255 M
Debt 2017 24 517 M
Yield 2017 2,73%
P/E ratio 2017 14,52
P/E ratio 2018 12,81
EV / Sales 2017 0,53x
EV / Sales 2018 0,50x
Capitalization 73 796 M
Chart CVS HEALTH
Duration : Period :
CVS Health Technical Analysis Chart | CVS | US1266501006 | 4-Traders
Technical analysis trends CVS HEALTH
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 85,8 $
Spread / Average Target 18%
EPS Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
David M. Denton Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
CVS HEALTH-7.38%74 029
WALGREENS BOOTS ALLIANCE-13.55%71 187
EXPRESS SCRIPTS HOLDING CO-0.93%38 734
MCKESSON CORPORATION6.81%32 065
CARDINAL HEALTH INC-18.72%18 989
AMERISOURCEBERGEN CORP.9.90%18 923